ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0668

There Are No Shortcuts: Electronic Health Record-Generated Tool Does Not Reflect Medication Adherence in Patients with SLEin Bronx, NY

Kiera Brennan1, Kai Sun2, Anitha Ramu1, Juliann Allen1, Justina Shafik1 and Noa Schwartz3, 1Albert Einstein College of Medicine, Bronx, NY, 2Duke University, Durham, NC, 3Albert Einstein College of Medicine, New York, NY

Meeting: ACR Convergence 2024

Keywords: health behaviors, socioeconomic factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 16, 2024

Title: SLE – Treatment Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Nonadherence to hydroxychloroquine (HCQ) is associated with poor outcomes in SLE.1 Electronic Health Record (EHR) platforms collect data on patient medication access through dispensing reports from external pharmacies, potentially serving as a surrogate measure of patient medication adherence. To assess the accuracy of this tool in a diverse, urban cohort of SLE patients, we compared the medication adherence score calculated through Epic EHR, the most adopted EHR worldwide,2 to blood levels of HCQ, a direct measurement of medication adherence.3 

Methods: Retrospective analysis of 120 patients, all satisfying the 2019 EULAR/ACR Criteria, at a tertiary academic medical center in the Bronx, NY, who had HCQ blood levels measured between January 2023 and May 2024. Blood levels ≥750 ng/mL were considered therapeutic and those ≤200 ng/mL were considered underexposed. Epic medication possession ratios (MPR) are determined by comparing the outpatient medication list in Epic with the number of times a medication has been dispensed leading to a percentage score, with ≥80% considered adherent. Based on their home addresses, patients were classified into state-specific deciles of the Area Deprivation Index (ADI), a validated tool that quantifies disadvantage on a neighborhood level, with higher scores indicating greater socioeconomic disadvantage.4,5 Congruency between Epic-derived MPR and blood HCQ levels was analyzed for the whole group and at the levels of low, moderate, and high ADIs. 

Results: Of 120 patients, 60 (50%) had therapeutic blood levels of HCQ and 21 (18%) were underexposed. For patients with therapeutic HCQ levels, only 52% had MPRs ≥80%, while 43% of those who were underexposed still had MPRs ≥80%. Among underexposed patients who were prescribed optimal HCQ dosing (5 mg/kg, n=10), only 20% had MPRs ≤25%. Of the 57 patients with MPRs ≥80%, 30 (53%) had therapeutic HCQ levels; and of the 27 patients with MPRs ≤25%, only 12 (44%) had subtherapeutic HCQ levels. Congruency of blood levels of HCQ and MPR was not significantly different between ADI levels.  

Conclusion: Overall, MPRs generated by Epic EHR did not correspond with blood HCQ levels, even when accounting for dosing strategy and ADI. For those patients with ≤200 ng/mL blood HCQ, 43% had MPRs ≥80%, suggesting that disease education and health literacy may be a more significant barrier to medication adherence than access to medication in this population. These findings indicate that blood HCQ levels should continue to be used to guide patient discussions regarding medication adherence, while readily available EHR tools should be used with caution.

Supporting image 1

Characteristics of study cohort

Supporting image 2

Congruency between HCQ Levels and Epic Medication Possession Ratio (MPR)

Supporting image 3

Congruency of HCQ levels with Epic MPR by ADI


Disclosures: K. Brennan: None; K. Sun: None; A. Ramu: None; J. Allen: None; J. Shafik: None; N. Schwartz: None.

To cite this abstract in AMA style:

Brennan K, Sun K, Ramu A, Allen J, Shafik J, Schwartz N. There Are No Shortcuts: Electronic Health Record-Generated Tool Does Not Reflect Medication Adherence in Patients with SLEin Bronx, NY [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/there-are-no-shortcuts-electronic-health-record-generated-tool-does-not-reflect-medication-adherence-in-patients-with-slein-bronx-ny/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/there-are-no-shortcuts-electronic-health-record-generated-tool-does-not-reflect-medication-adherence-in-patients-with-slein-bronx-ny/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology